McLaren-Port Huron is a clinical research site located in Port Huron, Michigan, United States 48060.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
McLaren-Port Huron has participated in 52 clinical trials with 36 currently active.
Therapeutic areas: Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
McLaren-Port Huron has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McLaren-Port Huron has 52 clinical trials on record, with 36 currently active. Their work covers Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.
Yes — McLaren-Port Huron holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.